Case reports in the use of vitamin C based regimen in prophylaxis and management of COVID-19 among Nigerians

This case study was based on the novel opinion that daily intake of vitamin C can serve as a prophylactic and curative intervention for the coronavirus disease of 2019 (COVID-19) via homeostatic and epigenetic mechanisms. To substantiate this hypothesis, some Nigerians who used vitamin C based regimen consented to share their experience in the prevention and management of the coronavirus irrespective of their country of abode. Participants all agreed to the use of their information for the public, albeit anonymous, via appending their signatures on an informed consent form. The documented cases took place from March 15 to September 1, 2020, this was to allow for more time to be able to observe the participants. The study provided evidence that regular use of Ascorbic acid tablets and vitamin C enriched plants could improve the immunity needed against the infection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Using decoction of some vitamin C enriched plants for the management of COVID-19 in Jos, Nigeria: A case report

The worldwide influence of coronavirus disease 2019 (COVID-19) pandemic compelled the global health organizations to prioritize the situation over all other related community health issues. The lack of specific treatment modalities against COVID-19 is a major concern nowadays. Here is a case of a 44-year-old man of 176 cm height and 87 kg body weight, who took some powdered mixture equally composed of bitter kola, cinnamon, garlic, ginger, and turmeric sweetened with three teaspoons full of honey. All ingredients were dissolved in 100 ml hot water and taken three times a day during isolation as a positive COVID-19 patient and reversed all associated signs and symptoms after 7 days as confirmed with rapid diagnostic techniques (RDTs). This case revealed that homogenized herbal tea in Jos Nigeria possesses a potential therapeutic that could be a treatment protocol against COVID-19